Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.

IF 3.1 2区 医学 Q2 CLINICAL NEUROLOGY
Journal of Neuro-Oncology Pub Date : 2025-12-01 Epub Date: 2025-09-09 DOI:10.1007/s11060-025-05225-4
Jianxin Zhao, Lijun Liang, Jixian Li, Qi Li, Fei Li, Lei Niu, Caiqiang Xue, Weiwei Fu, Yingchao Liu, Shuangshuang Song, Xuejun Liu
{"title":"Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.","authors":"Jianxin Zhao, Lijun Liang, Jixian Li, Qi Li, Fei Li, Lei Niu, Caiqiang Xue, Weiwei Fu, Yingchao Liu, Shuangshuang Song, Xuejun Liu","doi":"10.1007/s11060-025-05225-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale and objectives: </strong>Double expression lymphoma (DEL) is an independent high-risk prognostic factor for primary CNS lymphoma (PCNSL), and its diagnosis currently relies on invasive methods. This study first integrates radiomics and habitat radiomics features to enhance preoperative DEL status prediction models via intratumoral heterogeneity analysis.</p><p><strong>Materials and methods: </strong>Clinical, pathological, and MRI imaging data of 139 PCNSL patients from two independent centers were collected. Radiomics, habitat radiomics, and combined models were constructed using machine learning classifiers, including KNN, DT, LR, and SVM. The AUC in the test set was used to evaluate the optimal predictive model. DCA curve and calibration curve were employed to evaluate the predictive performance of the models. SHAP analysis was utilized to visualize the contribution of each feature in the optimal model.</p><p><strong>Results: </strong>For the radiomics-based models, the Combined radiomics model constructed by LR demonstrated better performance, with the AUC of 0.8779 (95% CI: 0.8171-0.9386) in the training set and 0.7166 (95% CI: 0.497-0.9361) in the test set. The Habitat radiomics model (SVM) based on T1-CE showed an AUC of 0.7446 (95% CI: 0.6503- 0.8388) in the training set and 0.7433 (95% CI: 0.5322-0.9545) in the test set. Finally, the Combined all model exhibited the highest predictive performance: LR achieved AUC values of 0.8962 (95% CI: 0.8299-0.9625) and 0.8289 (95% CI: 0.6785-0.9793) in training and test sets, respectively.</p><p><strong>Conclusion: </strong>The Combined all model developed in this study can provide effective reference value in predicting the DEL status of PCNSL, and habitat radiomics significantly enhances the predictive efficacy.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"1103-1113"},"PeriodicalIF":3.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-05225-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale and objectives: Double expression lymphoma (DEL) is an independent high-risk prognostic factor for primary CNS lymphoma (PCNSL), and its diagnosis currently relies on invasive methods. This study first integrates radiomics and habitat radiomics features to enhance preoperative DEL status prediction models via intratumoral heterogeneity analysis.

Materials and methods: Clinical, pathological, and MRI imaging data of 139 PCNSL patients from two independent centers were collected. Radiomics, habitat radiomics, and combined models were constructed using machine learning classifiers, including KNN, DT, LR, and SVM. The AUC in the test set was used to evaluate the optimal predictive model. DCA curve and calibration curve were employed to evaluate the predictive performance of the models. SHAP analysis was utilized to visualize the contribution of each feature in the optimal model.

Results: For the radiomics-based models, the Combined radiomics model constructed by LR demonstrated better performance, with the AUC of 0.8779 (95% CI: 0.8171-0.9386) in the training set and 0.7166 (95% CI: 0.497-0.9361) in the test set. The Habitat radiomics model (SVM) based on T1-CE showed an AUC of 0.7446 (95% CI: 0.6503- 0.8388) in the training set and 0.7433 (95% CI: 0.5322-0.9545) in the test set. Finally, the Combined all model exhibited the highest predictive performance: LR achieved AUC values of 0.8962 (95% CI: 0.8299-0.9625) and 0.8289 (95% CI: 0.6785-0.9793) in training and test sets, respectively.

Conclusion: The Combined all model developed in this study can provide effective reference value in predicting the DEL status of PCNSL, and habitat radiomics significantly enhances the predictive efficacy.

多参数MRI放射组学联合栖息地放射组学预测原发性中枢神经系统淋巴瘤双表达状态:一项双中心研究。
理由和目的:双表达淋巴瘤(DEL)是原发性中枢神经系统淋巴瘤(PCNSL)的独立高危预后因素,其诊断目前依赖于侵入性方法。本研究首先结合放射组学和栖息地放射组学特征,通过肿瘤内异质性分析来增强术前DEL状态预测模型。材料与方法:收集来自两个独立中心的139例PCNSL患者的临床、病理及MRI影像资料。利用KNN、DT、LR和SVM等机器学习分类器构建放射组学、栖息地放射组学和组合模型。用测试集中的AUC来评价最优预测模型。采用DCA曲线和标定曲线对模型的预测性能进行了评价。利用SHAP分析可视化各特征在最优模型中的贡献。结果:对于基于放射组学的模型,LR构建的联合放射组学模型表现出更好的性能,训练集的AUC为0.8779 (95% CI: 0.8171-0.9386),测试集的AUC为0.7166 (95% CI: 0.497-0.9361)。基于T1-CE的生境放射组学模型(SVM)在训练集的AUC为0.7446 (95% CI: 0.6503 ~ 0.8388),在测试集的AUC为0.7433 (95% CI: 0.5322 ~ 0.9545)。最后,组合所有模型表现出最高的预测性能:LR在训练集和测试集上分别达到0.8962 (95% CI: 0.8299-0.9625)和0.8289 (95% CI: 0.6785-0.9793)的AUC值。结论:本研究建立的Combined all模型可为预测PCNSL的DEL状态提供有效的参考价值,其中栖息地放射组学显著提高了预测效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信